Kardiovaskuläre Konstellation bei der Mutter während Schwangerschaft, Wehentätigkeit und Tokolyse — eine Literaturübersicht

  • M. Hermer

Zusammenfassung

Den kardiovaskulären Nebenwirkungen von Betasympathomimetika bei der Tokolyse wurde wegen der Häufigkeit ihres Auftretens und ihrer ausgeprägten subjektiven Komponente stets eine große Aufmerksamkeit gewidmet. Eine Fülle von Untersuchungen und mehrere Übersichten (z.B. 15, 16, 20, 21, 26, 28, 33, 53) über die Wirkungen von Betamimetika auf Herz und Kreislauf sowie ständige Bemühungen, gerade solche Nebenwirkungen mit Hilfe einer Zusatztherapie (Kalziumantagonisten, Betablocker, Magnesium) zu reduzieren bzw zu antagonisieren, unterstreichen die Bedeutung dieser Fragestellung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adams JQ (1954) Cardiovascular physiology in normal pregnancy: studies with dye dilution techniques. Am J Obstet Gynecol 67: 741–759PubMedGoogle Scholar
  2. 2.
    Adams JQ et al. (1958) Alterations in cardiovascular physiology during labor. Am Obstet Gynecol 12: 542–549Google Scholar
  3. 3.
    Altura BT et al. (1977) Influence of sex hormones, oral contraceptives and pregnancy on vascular muscle and its reactivity. In: Carrier O, Shibata S (eds) Factors influencing vascular reactivity. IgakuShoin Ltd, TokyoGoogle Scholar
  4. 4.
    Benedetti TJ (1983) Maternal complications of parenteral ß-sympathomimetic therapy for premature labor. Am J Obstet Gynecol 145: 1–6PubMedGoogle Scholar
  5. 5.
    Bieniarz J et al. (1974) Cardiac output during ritodrine treatment in premature labor. Am J Obstet Gynecol 118: 910–920PubMedGoogle Scholar
  6. 6.
    Boyle DM et al. (1966) The electrocardiographic S-T segment in pregnancy. J Obstet Gynecol Br Commonw 73: 986–987CrossRefGoogle Scholar
  7. 7.
    Burwell CS et al. (1986) Heart Disease and Pregnancy. Little, Brown and Company, Boston/TorontoGoogle Scholar
  8. 8.
    Chesley LC (1980) Hypertensive disorders in pregnancy. Appleton-Century-Crofts, New YorkGoogle Scholar
  9. 9.
    Clapp JF (1985) Maternal heart rate in pregnancy. Am J Obstet Gynecol 152: 659–660PubMedGoogle Scholar
  10. 10.
    Cunningham I (1966) Cardiovascular physiology of labor and delivery. J Obstet Gynecol Br Commonw 73: 498–503CrossRefGoogle Scholar
  11. 11.
    Elkayam U, Gleicher N (1982) Cardiac Problems in Pregnancy - Diagnosis and Management of Maternal and Fetal Disease. Alan R Liss, Inc, New YorkGoogle Scholar
  12. 12.
    Friedberg V (1981) Physiologische Veränderungen des Gesamtorganismus. In: Käser O et al. (Hrsg) Gynäkologie und Geburtshilfe. Georg Thieme, Stuttgart New York, S 331–370Google Scholar
  13. 13.
    Gleicher N et al. (1981) Wolff-Parkinson-White syndrome in pregnancy. Obstet Gynecol 58: 748–752PubMedGoogle Scholar
  14. 14.
    Goeltner E et al. (1967) Intrathorakaler Venendruck, Puls und Atmung während der Eröffnungswehen. Gynäcologia 163: 235–240Google Scholar
  15. 15.
    Grospietsch G (1990) Nebenwirkungen der betamimetischen tokolytischen Therapie bei der Mutter und Möglichkeiten der Antagonisierung. In: Jung H, Hermer M (Hrsg) Tokolyse und Betamimetika. Steinkopff, Darmstadt, S 35–53CrossRefGoogle Scholar
  16. 16.
    Grospietsch G (1993) Wirkungen bzw. Nebenwirkungen der betamimetischen tokolytischen Therapie bei Mutter und Kind. In: Spätling L, Fallenstein F (Hrsg) Bolustokolyse in Theorie und Praxis. Steinkopff, Darmstadt, S 143–162CrossRefGoogle Scholar
  17. 17.
    Hadi H et al. (1989) Cardiac isoenzymes and electrocardiographic changes during ritodrine tocolysis. Am J Obstet Gynecol 161: 318–321PubMedGoogle Scholar
  18. 18.
    Hendricks SK, Katz M (1990) Effects of ritodrine tocolysis on cardiac isozymes and electrocardiography. Am J Obstet Gynecol 163: 699–701PubMedGoogle Scholar
  19. 19.
    Henricks CH et al. (1956) Cardiac output during labor. Am J Obstet Gynecol 71: 953–972Google Scholar
  20. 20.
    Hermer M (1986) Herz-Kreislauf-Wirkungen des ß2-Sympathomimetikums Partusisten auf die Schwangere (I). Medwelt 37: 306–309Google Scholar
  21. 21.
    Hermer M (1986) Herz-Kreislauf-Wirkungen des ßZ-Sympathomimetikums Partusisten auf die Schwangere (II). Medwelt 37: 735–739Google Scholar
  22. 22.
    Hettenbach A et al. (1990) Einfluß von Magnesiumsulfat bei betamimetischerTokolyse auf Parameter des Wasser-Elektrolythaushalts. In: Weidinger H (Hrsg) Medizin–Management–Magnesium. Blackwell Ueberreuter Wissenschaft Berlin, S 272–296Google Scholar
  23. 23.
    Hohmann M et al. (1990) Maternale kardiovaskuläre Adaptation während der Schwangerschaft. Geburtsh Frauenheilk 50: 255–262PubMedCrossRefGoogle Scholar
  24. 24.
    Hollander A et al. (1943) Roentgenologic and electrocardiographic changes in the normal heart during pregnancy. Amer Heart J 26: 364–376CrossRefGoogle Scholar
  25. 25.
    Hytten F et al. (1980) Clinical physiology in obstetrics. Blackwell Scientific Publications, OxfordGoogle Scholar
  26. 26.
    Irmer M (1986) Nebenwirkungen der Beta-2-Adrenergika auf Stoffwechsel und Herz-KreislaufSystem. Therapiewoche (Karlsruhe) 36: 106–115Google Scholar
  27. 27.
    Kjeldsen J (1979) Hemodynamic investigations during labor and delivery. Acta Obstet Gynecol Scand, Suppl 89Google Scholar
  28. 28.
    Kress P et al. (1987) Tokolyse mit Beta-S.ympathikomimetika. Therapiewoche 37: 4494–4499Google Scholar
  29. 29.
    Lindheimer MD et al. (1973) Sodium and diuretics in pregnancy. N Engl J Med 288: 891PubMedCrossRefGoogle Scholar
  30. 30.
    Lund CJ et al. (1967) Blood volume during pregnancy. Am J Obstet Gynecol 98: 393–403Google Scholar
  31. 31.
    MacGillivray I et al. (1958) Total exchangable sodium and potassium in non-pregnant woman and in normal and preeclamptic pregnancy. Lancet 2: 1090PubMedCrossRefGoogle Scholar
  32. 32.
    Metcalfe J et al. (1988) Maternal physiology during gestation. In: Knobil E, Neill J (eds) The physiology of reproduction. Raven Press, Ltd, New YorkGoogle Scholar
  33. 33.
    Meyer J (1978) Kardiale Nebenwirkungen der Beta-Adrenergika. In: Jung H, Friedrich E (Hrsg) Fenoterol (Partusisten®) bei der Behandlung in der Geburtshilfe und Perinatologie. Georg Thieme, Stuttgart, S 107–114Google Scholar
  34. 34.
    Michalak D et al. (1983) Myocardial ischemia: A complication of ritodrine tocolysis. Am J Obstet Gynecol 146: 861–862PubMedGoogle Scholar
  35. 35.
    Mols P et al. (1988) How Does Salbutamol Improve the Ventricular Performance in Patients with Chronic Obstructive Pulmonary Disease? J Cardiovasc Pharmacol 12: 127–133PubMedCrossRefGoogle Scholar
  36. 36.
    Müller H et al. (1985) Haemodynamic Effects of Fenoterol for Labour Inhibition during Spinal or Epidural Anaesthesia. Gynecol Obstet Invest 19: 64–72PubMedCrossRefGoogle Scholar
  37. 37.
    Mulders LGM et al. (1987) A study of maternal ECG characteristics before and during intravenous tocolysis with β-sympathicomimetics. Acta Obstet Gynecol Scand 66: 417–420PubMedCrossRefGoogle Scholar
  38. 38.
    Oram S et al. (1961) Innocent depression of the S-T segment and flattening of the T-wave during pregnancy. J Obst Gynaecol Br Commonw 68: 765–770CrossRefGoogle Scholar
  39. 39.
    Perloff JK (1980) Pregnancy and cardiovascular disease. In: Braumwald (ed) Heart Disease. W.B. Saunders Company, Philadelphia, pp 1871–1891Google Scholar
  40. 40.
    Pyorala T (1966) Cardiovascular response to the upright position during pregnancy. Acta Obstet Gynec Scand 45Google Scholar
  41. 41.
    Rose D et al. (1956) Catheterization studies of cardiac hemodynamics in normal and pregnant women with reference to left ventricular work. Am J Obstet Gynecol 72: 233–246PubMedGoogle Scholar
  42. 42.
    Schäfer H et al. (1963) Electrocardiography. In: Handbook of Physiology, Section 2: Circulation. Bd I American Physiol Society, Washington, DC, p 323Google Scholar
  43. 43.
    Scheitza E et al. (1976) Effects of the tocolytic agent fenoterol on electrolyte metabolism, plasma aldosterone and renin levels in late pregnancy. In: 5th European Congress of Perinatal Medicine, Uppsala/Schweden, June 9–12, Abstr No 53Google Scholar
  44. 44.
    Schuhmann R et al. (1982) Changes in Maternal Cardiovascular Parameters During Normal Pregnancy and Their Significance in Tocolytic Therapy. In: Jung H, Lamberti (eds) Beta-mimetic Drugs in Obstetrics and Perinatology. Georg Thieme, Stuttgart New York, pp 102–104Google Scholar
  45. 45.
    Schwartz DB et al. (1979) The effect of pregnancy on the frontal plane QRS axis. J Electrocardiol 12: 279–281PubMedCrossRefGoogle Scholar
  46. 46.
    Szekely P et al. (1974) Heart disease and pregnancy. Churchill Livingstone, EdinburghGoogle Scholar
  47. 47.
    Tye KH et al. (1980) Angina Pectoris Associated With Use of Terbutaline for Premature Labor. JAMA 244: 692–693PubMedCrossRefGoogle Scholar
  48. 48.
    Ueland K et al. (1969) Maternal cardiovascular dynamics. III. Labor and delivery under local and caudal analgesia. Am J Obstet Gynecol 103: 8–18PubMedGoogle Scholar
  49. 49.
    Ueland K et al. (1969) Maternal cardiovascular dynamics. IV. The influence of gestational cardiovascular response to posture and exercise. Am J Obstet Gynecol 104: 856PubMedGoogle Scholar
  50. 50.
    Upshaw CB Jr (1970) A study of maternal electrocardiograms recorded during labor and delivery. Am J Obstet Gynecol 107: 17–27PubMedGoogle Scholar
  51. 51.
    Watanabe M et al. (1963) Secretion rate of aldosterone in normal pregnancy. J Clin Invest 42: 1619PubMedCrossRefGoogle Scholar
  52. 52.
    Winner W et al. (1966) Cardiovascular responses to labor and delivery. Am J Obstet Gynecol 95: 1104–1114PubMedGoogle Scholar
  53. 53.
    Wolff F et al. (1986) Cardiopulmonary Effects of Betamimetic Tocolytic and Glucocorticoid Therapy in Pregnant Women. Arch Gynecol 239: 49–58PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1994

Authors and Affiliations

  • M. Hermer
    • 1
  1. 1.Boehringer Ingelheim KGIngelheimDeutschland

Personalised recommendations